SCHEMBL24006403

SCHEMBL24006403

CCNc1cc(O)c2c(c1)oc1c(C)ccc(C(C)C)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 3/20 0.36
CYP3A4 P08684 2/20 0.33
TSHR P16473 1/20 0.33
RECQL P46063 1/20 0.33
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
TRPA1 O75762 1/20 0.32
LMNA P02545 1/20 0.32
CHRM1 P11229 1/20 0.32
SLC6A2 P23975 1/20 0.32
ADRA1A P35348 1/20 0.32
HTR2B P41595 1/20 0.32
FBP1 P09467 2/20 0.32
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32
CNR2 P34972 1/20 0.32
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
GAA P10253 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23008681 0.81 ALDH1A1 (0.52) GPR55TSHRALDH1A1HTTTRPA1
SCHEMBL22622533 0.80 TRPA1 (0.45) GPR55CYP3A4TSHRALDH1A1HTT
SCHEMBL13214160 0.76 ALDH1A1 (0.55) GPR55CYP3A4TSHRALDH1A1HTT
SCHEMBL29349816 0.76 ALDH1A1 (0.55) GPR55CYP3A4TSHRALDH1A1HTT
SCHEMBL5348298 0.69 GPR55 (0.49) GPR55CYP3A4TSHRALDH1A1TRPA1
SCHEMBL27527597 0.64 CYP3A4 (0.39) CYP3A4TSHRRECQLALDH1A1HTT
SCHEMBL3962037 0.64 ALDH1A1 (0.54) CYP3A4TSHRRECQLALDH1A1TRPA1
SCHEMBL16079756 0.61 ALDH1A1 (0.51) GPR55CYP3A4TSHRALDH1A1HTT
SCHEMBL5341413 0.61 CYP3A4 (0.46) GPR55CYP3A4TSHRALDH1A1TRPA1
SCHEMBL13487422 0.61 MAPT (0.37) CYP3A4TSHRRECQLALDH1A1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210346277-A1 Pharmaceutical Formulation KLARIA PHARMA HOLDING AB (SE) 2021-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210346277-A1 Pharmaceutical Formulation ALG1, CNR1, CNR2 GPR55 461/4885CYP3A4 4368/4885TSHR 3586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.